Literature DB >> 10229069

Baclofen and antidepressant--induced antinociception in formalin test: possible GABA(B) mechanism involvement.

M Sabetkasai1, N Khansefid, S H Yahyavi, M R Zarrindast.   

Abstract

In this study, the influences of GABA(B) agents on antidepressant-induced antinociception in the mouse formalin test have been investigated. The GABA(B) receptor agonist baclofen (2.5, 5 and 10 mg/kg) induced a dose-dependent antinociception in the second phase of the formalin test. This response was inhibited by the GABA(B) receptor antagonist, CGP35348 [P-(3-aminopropyl)-p-diethoxymethyl-phosphinic acid], in a dose-dependent manner. The antagonist by itself also induced antinociception. Single administration of the antidepressants citalopram (10, 20, 40 and 80 mg/kg), desipramine (20, 40, 80 mg/kg) or imipramine (10, 20 and 40 mg/kg) also induced antinociception in both phases of the formalin test. CGP35348 (100 and 200 mg/kg) pretreatment reduced the response induced by the tricyclic antidepressants. A combination of baclofen with the tricyclic antidepressant did not potentiate antinociception induced by antidepressants, but a decrease in the response induced by higher dose of baclofen was shown. It is concluded that GABA mechanism(s) may modulate the antidepressant-induced antinociception.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229069     DOI: 10.1007/s002130050909

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  1 in total

1.  Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo.

Authors:  Vijayan Gangadharan; Nitin Agarwal; Stefan Brugger; Imgard Tegeder; Bernhard Bettler; Rohini Kuner; Martina Kurejova
Journal:  Mol Pain       Date:  2009-11-19       Impact factor: 3.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.